| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1177/106002809302701014 |
| P698 | PubMed publication ID | 8251694 |
| P2093 | author name string | S A Tailor | |
| M J Rybak | |||
| E M Bailey | |||
| P2860 | cites work | Bacteremia caused by hemolytic, high-level gentamicin-resistant Enterococcus faecalis | Q24645094 |
| The rate of bactericidal action of penicillin in vitro as a function of its concentration, and its paradoxically reduced activity at high concentrations against certain organisms | Q24681048 | ||
| Vancomycin therapy of bacterial endocarditis | Q28319898 | ||
| Antimicrobial Therapy of Experimental Enterococcal Endocarditis | Q30449227 | ||
| Characterization and comparison of two penicillinase-producing strains of Streptococcus (Enterococcus) faecalis | Q30451744 | ||
| Transferable vancomycin and teicoplanin resistance in Enterococcus faecium | Q34042099 | ||
| Molecular basis for vancomycin resistance in Enterococcus faecium BM4147: biosynthesis of a depsipeptide peptidoglycan precursor by vancomycin resistance proteins VanH and VanA. | Q34968575 | ||
| In vitro activities of quinolones against enterococci resistant to penicillin-aminoglycoside synergy | Q35243584 | ||
| Susceptibility and bactericidal activity studies of four beta-lactamase-producing enterococci | Q35244504 | ||
| Ampicillin-resistant enterococcal species in an acute-care hospital | Q35274647 | ||
| Phenotypic and genotypic heterogeneity of glycopeptide resistance determinants in gram-positive bacteria | Q35276250 | ||
| Comparative in vitro activities of sparfloxacin (CI-978; AT-4140) and other antimicrobial agents against staphylococci, enterococci, and respiratory tract pathogens | Q35283618 | ||
| Daptomycin (LY146032) treatment of experimental enterococcal endocarditis | Q35309352 | ||
| In vitro susceptibility studies of vancomycin-resistant Enterococcus faecalis | Q35350299 | ||
| Efficacy of teicoplanin for enterococcal infections: 63 cases and review | Q35350485 | ||
| Continuous-infusion ampicillin therapy of enterococcal endocarditis in rats | Q35536118 | ||
| WIN 57273, a new fluoroquinolone with enhanced in vitro activity versus gram-positive pathogens | Q35565226 | ||
| Heterogeneity of plasmids determining high-level resistance to gentamicin in clinical isolates of Streptococcus faecalis | Q35574158 | ||
| In vitro activity of LY146032 against staphylococci, streptococci, and enterococci | Q35575774 | ||
| Synergism of vancomycin-gentamicin and vancomycin-streptomycin against enterococci | Q35651761 | ||
| Comparison of two beta-lactamase-producing strains of Streptococcus faecalis | Q35653650 | ||
| Emergence and nosocomial transmission of ampicillin-resistant enterococci | Q35836173 | ||
| Isolation of a beta-lactamase-producing, aminoglycoside-resistant strain of Enterococcus faecium | Q35836603 | ||
| Antimicrobial susceptibility changes in Enterococcus faecalis following various penicillin exposure regimens | Q35843281 | ||
| Nosocomial Bacteremia Due to Enterococcus faecalis without Endocarditis | Q36260796 | ||
| Enterococcal Endocarditis | Q36260808 | ||
| Enterococcal Infections in Surgical Patients: The Mystery Continues | Q36260834 | ||
| High-level, plasmid-borne resistance to gentamicin in Streptococcus faecalis subsp. zymogenes | Q36485945 | ||
| Effects of combinations of beta-lactams, daptomycin, gentamicin, and glycopeptides against glycopeptide-resistant enterococci | Q36752594 | ||
| Influence of low-level resistance to vancomycin on efficacy of teicoplanin and vancomycin for treatment of experimental endocarditis due to Enterococcus faecium | Q36754480 | ||
| Aminoglycoside-inactivating enzymes in clinical isolates of Streptococcus faecalis. An explanation for resistance to antibiotic synergism | Q37031023 | ||
| Recent taxonomic changes in the genus Enterococcus | Q37809815 | ||
| Clinical manifestations of enterococcal infection | Q37909567 | ||
| Intra-abdominal sepsis after hepatic resection. | Q38220932 | ||
| Antimicrobial treatment of infective endocarditis due to viridans streptococci, enterococci, and staphylococci | Q38603783 | ||
| Species-Specific Resistance to Antimicrobial Synergism in Streptococcus faecium and Streptococcus faecalis | Q39683869 | ||
| Inducible, transferable resistance to vancomycin in Enterococcus faecalis A256 | Q39814923 | ||
| Vancomycin resistance is encoded on a pheromone response plasmid in Enterococcus faecium 228 | Q39815434 | ||
| Efficacy of teicoplanin in two dosage regimens for experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin | Q39815914 | ||
| Activity of glycopeptides against vancomycin-resistant gram-positive bacteria | Q39819863 | ||
| In vitro and in vivo activity of ciprofloxacin against enterococci isolated from patients with infective endocarditis | Q39827844 | ||
| Treatment of experimental endocarditis caused by a beta-lactamase-producing strain of Enterococcus faecalis with high-level resistance to gentamicin | Q39833014 | ||
| Therapeutic efficacy of teicoplanin in experimental enterococcal endocarditis | Q39833705 | ||
| Minimal concentrations of aminoglycoside that can synergize with penicillin in enterococcal endocarditis | Q39855794 | ||
| 'Breakthrough' enterococcal septicemia in surgical patients. 19 cases and a review of the literature | Q40206291 | ||
| Defective killing of enterococci: a common property of antimicrobial agents acting on the cell wall | Q40282242 | ||
| Antimicrobial susceptibility and molecular epidemiology of beta-lactamase-producing, aminoglycoside-resistant isolates of Enterococcus faecalis | Q40284223 | ||
| Studies on antibiotic syngerism against enterococci. II. Effect of various antibiotics on the uptake of 14 C-labeled streptomycin by enterococci | Q40325773 | ||
| Resistance to Six Aminoglycosidic Aminocyclitol Antibiotics Among Enterococci: Prevalence, Evolution, and Relationship to Synergism with Penicillin | Q40354256 | ||
| Synergy of penicillin and decreasing concentration of aminoglycosides against enterococci from patients with infective endocarditis | Q40621611 | ||
| A prospective analysis of hospital-acquired fever in obstetric and gynecologic patients | Q40843970 | ||
| In vitro activity of ampicillin or vancomycin combined with gentamicin or streptomycin against enterococci | Q41029958 | ||
| Aminoglycoside-resistant enterococci | Q41247748 | ||
| Influence of gentamicin dose size on the efficacies of combinations of gentamicin and penicillin in experimental streptomycin-resistant enterococcal endocarditis | Q42151557 | ||
| Treatment of streptomycin-susceptible and streptomycin-resistant enterococcal endocarditis | Q42249001 | ||
| Transferable beta-lactamase. A new mechanism for in vitro penicillin resistance in Streptococcus faecalis | Q42790004 | ||
| Enterococcal bacteremia in two large community teaching hospitals | Q43431377 | ||
| Enterococcal endocarditis in heroin addicts | Q43445959 | ||
| Infections of Cerebrospinal Fluid Shunts: Epidemiology, Clinical Manifestations, and Therapy | Q43586466 | ||
| Study on pathogenesis of Enterococcus faecalis in urinary tract | Q43611989 | ||
| Enterococcal superinfection in patients treated with ciprofloxacin | Q43833762 | ||
| beta-Lactamase production in experimental endocarditis due to aminoglycoside-resistant Streptococcus faecalis | Q44162423 | ||
| High-level gentamicin resistance in Enterococcus faecalis bacteremia | Q44273048 | ||
| Concomitant high-level vancomycin and penicillin resistance in clinical isolates of enterococci | Q44481685 | ||
| Transfer of Streptococcus faecalis and Streptococcus faecium to the Genus Enterococcus nom. rev. as Enterococcus faecalis comb. nov. and Enterococcus faecium comb. nov. | Q45308681 | ||
| Enterococcus avium nom. rev., comb. nov.; E. casseliflavus nom. rev., comb. nov.; E. durans nom. rev., comb. nov.; E. gallinarum comb. nov.; and E. malodoratus sp. nov. | Q45308917 | ||
| Enterococcus mundtii sp. nov. | Q45310935 | ||
| Urinary tract etiology of bloodstream infections in hospitalized patients | Q46171715 | ||
| Infections Due to Beta-Lactamase-producing, High-Level Gentamicin-resistant Enterococcus faecalis | Q46794893 | ||
| Major trends in the microbial etiology of nosocomial infection. | Q54288421 | ||
| Relapsing native-valve enterococcal endocarditis: a unique cure with oral ciprofloxacin combination drug therapy. | Q54291144 | ||
| Comparison of four methods for testing high-level aminoglycoside resistance in enterococci. | Q54330876 | ||
| Prevalence and susceptibility of highly gentamicin resistant Enterococcus faecalis in a south London teaching hospital. | Q54357127 | ||
| Interaction of ciprofloxacin with ampicillin and vancomycin for Streptococcus faecalis. | Q54386325 | ||
| A comparison of the in-vitro activity of seventeen antibiotics against Streptococcus faecalis. | Q54401337 | ||
| Resistance of enterococci to antibiotic combinations. | Q54426049 | ||
| High-level resistance to gentamicin in Streptococcus faecalis: risk factors and evidence for exogenous acquisition of infection. | Q54427546 | ||
| High-level resistance to gentamicin in clinical isolates of enterococci. | Q54499755 | ||
| Enterococcal pneumonia. Occurrence in patients receiving broad-spectrum antibiotic regimens and enteral feeding. | Q54506151 | ||
| Synergy of Penicillin and Gentamicin against Enterococci | Q54663753 | ||
| Pathogenicity of enterococci in a rat model of fecal peritonitis. | Q54728263 | ||
| P433 | issue | 10 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | emerging pathogen | Q108429945 |
| P304 | page(s) | 1231-1242 | |
| P577 | publication date | 1993-10-01 | |
| P1433 | published in | Annals of Pharmacotherapy | Q4767858 |
| P1476 | title | Enterococcus, an emerging pathogen | |
| P478 | volume | 27 |
| Q33748332 | Aggregation and binding substances enhance pathogenicity in rabbit models of Enterococcus faecalis endocarditis |
| Q73330541 | Assessment of the synergistic interactions of levofloxacin and ampicillin against Enterococcus faecium by the checkerboard agar dilution and time-kill methods |
| Q83094724 | Clinical significance of bacteriuria with low colony counts of Enterococcus species |
| Q35388401 | Cloning of an Enterococcus faecalis endocarditis antigen: homology with adhesins from some oral streptococci |
| Q42114174 | Complete genome sequence of bacteriophage BC-611 specifically infecting Enterococcus faecalis strain NP-10011. |
| Q31313987 | Enterococci at the crossroads of food safety? |
| Q42144202 | Enterococcus faecalis grows on ascorbic acid |
| Q33984759 | Genomic relationships between Enterococcus faecium strains from different sources and with different antibiotic resistance profiles evaluated by restriction endonuclease analysis of total chromosomal DNA using EcoRI and PvuII |
| Q34409916 | Identification and imaging of peptides and proteins on Enterococcus faecalis biofilms by matrix assisted laser desorption ionization mass spectrometry |
| Q35126947 | In vitro activity of the trinem sanfetrinem (GV104326) against gram-positive organisms |
| Q38308385 | Insusceptibility to disinfectants in bacteria from animals, food and humans-is there a link to antimicrobial resistance? |
| Q72242859 | Intra-abdominal sepsis |
| Q34050420 | Intraspecies genomic groups in Enterococcus faecium and their correlation with origin and pathogenicity |
| Q81038934 | Occurrence of pS86/pEF47-related plasmids in gram-positive cocci |
| Q35136634 | Pharmacodynamic evaluation of a new glycopeptide, LY333328, and in vitro activity against Staphylococcus aureus and Enterococcus faecium |
| Q34423000 | Quantification of antibiotic in biofilm-inhibiting multilayers by 7.87 eV laser desorption postionization MS imaging. |
| Q34405651 | Ramoplanin: a lipoglycodepsipeptide antibiotic |
| Q44305886 | Rapid increase in the prevalence of antimicrobial drug resistance among enterococcal blood isolates in southern Israel |
| Q41142612 | Recent advances: antiinfectives |
| Q71848584 | Serological investigation of enterococcal infections using western blot |
| Q36880185 | Simulation of human gentamicin pharmacokinetics in an experimental Enterococcus faecalis endocarditis model |
| Q33666710 | Use of newer quinolones for the treatment of intraabdominal infections: focus on clinafloxacin |
Search more.